Literature DB >> 9702779

Directed selection of MIP-1 alpha neutralizing CCR5 antibodies from a phage display human antibody library.

J K Osbourn1, J C Earnshaw, K S Johnson, M Parmentier, V Timmermans, J McCafferty.   

Abstract

The seven trans-membrane chemokine receptor CCR-5 is a coreceptor for macrophage tropic HIV-1 strains. CCR-5 responds to a number of chemokines, including macrophage inflammatory protein (MIP)-1 alpha. We describe the use of MIP-1 alpha in a biotin tyramine-mediated proximity selection to guide the selection of CCR-5-specific phage antibodies from a large phage display human library. Proximity based selections resulted in a population of antibodies recognizing CCR-5 on primary CD4+ lymphocytes, none of which blocked MIP-1 alpha binding to cells. The selected population of phage antibodies were subsequently used as guide molecules for a second phase of selection that was carried out in the absence of MIP-1 alpha. This generated a panel of CCR-5-binding antibodies, of which around 20% inhibited MIP-1 alpha binding to CD4+. The single chain Fvs (scFv) generated by this step-back selection procedure also inhibited MIP-1 alpha-mediated calcium signaling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9702779     DOI: 10.1038/nbt0898-778

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  6 in total

1.  The Effects of Statistical Multiplicity of Infection on Virus Quantification and Infectivity Assays.

Authors:  Bhaven A Mistry; Maria R D'Orsogna; Tom Chou
Journal:  Biophys J       Date:  2018-06-19       Impact factor: 4.033

2.  Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5.

Authors:  W C Olson; G E Rabut; K A Nagashima; D N Tran; D J Anselma; S P Monard; J P Segal; D A Thompson; F Kajumo; Y Guo; J P Moore; P J Maddon; T Dragic
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 3.  CCR5 monoclonal antibodies for HIV-1 therapy.

Authors:  William C Olson; Jeffrey M Jacobson
Journal:  Curr Opin HIV AIDS       Date:  2009-03       Impact factor: 4.283

Review 4.  The role of phage display in therapeutic antibody discovery.

Authors:  Conrad E Z Chan; Angeline P C Lim; Paul A MacAry; Brendon J Hanson
Journal:  Int Immunol       Date:  2014-08-18       Impact factor: 4.823

5.  Structural and pharmacological characterization of novel potent and selective monoclonal antibody antagonists of glucose-dependent insulinotropic polypeptide receptor.

Authors:  Peter Ravn; Chaithanya Madhurantakam; Susan Kunze; Evelyn Matthews; Claire Priest; Siobhan O'Brien; Andie Collinson; Monika Papworth; Maria Fritsch-Fredin; Lutz Jermutus; Lambertus Benthem; Markus Gruetter; Ronald H Jackson
Journal:  J Biol Chem       Date:  2013-05-20       Impact factor: 5.157

Review 6.  Engineering therapeutic antibodies targeting G-protein-coupled receptors.

Authors:  Migyeong Jo; Sang Taek Jung
Journal:  Exp Mol Med       Date:  2016-02-05       Impact factor: 8.718

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.